Breaking News, Collaborations & Alliances

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

The parties say the strategic collaboration will create immediate value for customers.

Author Image

By: Patrick Lavery

Content Marketing Editor

The global contract research organization (CRO) Worldwide Clinical Trials is making an acquisition of Catalyst Clinical Research. Monetary terms are undisclosed at this time. Catalyst is a specialized oncology CRO most known for expertise in early-phase oncology trials. The strategic acquisition establishes Worldwide as an oncology-focused CRO that still maintains depth across multiple therapeutic areas. Worldwide, Catalyst Leaders Tout Acquisition “Bringing Worldwide and Catalyst toget...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters